Literature DB >> 1983899

The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State.

M R Karagas1, D B Thomas, G J Roth, L K Johnson, N S Weiss.   

Abstract

The reported incidence of malignant melanoma of the skin has steadily increased in the United States during the past three decades. Since the treatment of melanoma increasingly has been provided solely on an outpatient basis in recent years, it is likely that some cases of this disease are being missed by population-based tumor registries that do not consistently ascertain cases from sources outside the hospital setting. The population-based tumor registry of western Washington state has been identifying office-treated cases of cutaneous melanoma from records of private and hospital pathology laboratories. However, since laboratory records have often lacked information on place of residence, these cases have not been previously included in the calculation of incidence rates. In the present study, by determining the place of residence of these cases at the time of their diagnosis (by contacting the physician listed on their pathology reports), the authors found that there had been a growing amount of underreporting of cutaneous melanoma from 1974 through 1984. In western Washington state, the incidence of melanoma of the skin had been underestimated in registry rates by approximately 2% in 1974 and approximately 21% in 1984. This trend in the level of underenumeration has spuriously blunted the true increasing incidence of melanoma and may limit the ability to monitor and study this disease in the future.

Entities:  

Mesh:

Year:  1991        PMID: 1983899     DOI: 10.1093/oxfordjournals.aje.a115802

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.

Authors:  M A Weinstock; B Gardstein
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

2.  Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties.

Authors:  G Gong; A S Whittemore; D West; D H Moore
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

3.  Recent cohort trends in malignant melanoma by anatomic site in the United States.

Authors:  L K Dennis; E White; J A Lee
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

4.  Melanoma: linked temporal and latitude changes in the United States.

Authors:  J A Lee; J Scotto
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

5.  Cutaneous melanoma following cervical intra-epithelial neoplasia in western Washington State.

Authors:  E Y Shmulewitz; N S Weiss; S M Schwartz
Journal:  Cancer Causes Control       Date:  1993-05       Impact factor: 2.506

6.  Does where you live influence how your vestibular schwannoma is managed? Examining geographical differences in vestibular schwannoma treatment across the United States.

Authors:  Matthew L Carlson; Amy E Glasgow; Brandon R Grossardt; Elizabeth B Habermann; Michael J Link
Journal:  J Neurooncol       Date:  2016-06-22       Impact factor: 4.130

7.  Overview of ultraviolet radiation and cancer: what is the link? How are we doing?

Authors:  M A Weinstock
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

8.  Problems with registration of cutaneous malignant melanoma in England.

Authors:  J Melia; T Frost; R Graham-Brown; J Hunter; A Marsden; A du Vivier; A P Warin; J White; S Whitehead; M Wroughton
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.